Companies House true 2024-04-23 2025-04-25 false 15673774 uk-bus:Director1 2024-04-23 2025-04-25 15673774 uk-bus:Director2 2024-04-23 2025-04-25 15673774 2024-04-23 2025-04-25 15673774 2025-04-25 15673774 uk-bus:EntityHasNeverTraded 2024-04-23 2025-04-25 15673774 uk-bus:FRS102 2024-04-23 2025-04-25 15673774 uk-bus:FullAccounts 2024-04-23 2025-04-25 15673774 uk-bus:AuditExempt-NoAccountantsReport 2024-04-23 2025-04-25 15673774 uk-bus:OrdinaryShareClass1 2024-04-23 2025-04-25 15673774 uk-bus:OrdinaryShareClass2 2024-04-23 2025-04-25 15673774 uk-bus:OrdinaryShareClass3 2024-04-23 2025-04-25 15673774 uk-bus:PreferenceShareClass1 2024-04-23 2025-04-25 15673774 uk-bus:PreferenceShareClass2 2024-04-23 2025-04-25 15673774 uk-bus:PreferenceShareClass3 2024-04-23 2025-04-25 15673774 uk-core:ShareCapitalPreferenceShares 2025-04-25 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 15673774

ABL PHARMA UK LIMITED

Dormant Accounts

25 April 2025

ABL PHARMA UK LIMITED Registered Number 15673774

Balance Sheet as at 25 April 2025

2025
£
Called up share capital not paid
10000
Net assets
10000
Issued share capital
10000 Ordinary Shares of £ 1 each 10000
Total Shareholder funds
10000

STATEMENTS

  1. For the year ending 25 April 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 25 April 2025

And signed on their behalf by:
Issa MOUSSA MAHAMAT, Director